What's new

EMEA-002746-PIP01-20-M03

EMEA-002746-PIP01-20-M03

Jun 6, 2025 - 15:00
 0
EMEA-002746-PIP01-20-M03
EMEA-002746-PIP01-20-M03
Read More

Tags:

Previous Article

STAT+: Pharmalittle: We’re reading about GLP-1 drugs and eye disease, European p...

Next Article

EMEA-002736-PIP02-23

Related Posts

Timetable: Type II variation and worksharing applicatio...

May 23, 2025  0

Summary of opinion: Rezolsta, 22/05/2025 Positive

Summary of opinion: Rezolsta, 22/05/2025 Positive

May 23, 2025  0

Human medicines European public assessment report (EPAR): Teysuno, tegafur,gimeracil,oteracil, Date of authorisation: 14/03/2011, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR...

May 21, 2025  0